JANA HOLSMAN: Open Payments
NPI 1679239719 · JEFFERSON CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$401 in 20 payments from 11 companies in 2025. Trend: 2023 $64 · 2024 $246 · 2025 $401
Food & beverage: $401
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $78 |
| Lilly USA, LLC | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Eisai Inc. | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $20 |
| Viatris Specialty LLC | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: Wegovy, MOUNJARO, REXULTI, BREZTRI, Leqembi, VOQUEZNA, VRAYLAR, YUPELRI.
Industry payments across MO — which companies pay providers there.
